Patents Assigned to IQ Therapeutics BV
  • Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof
    Publication number: 20110059098
    Abstract: The invention fully humanized monoclonal antibodies that neutralize Bacillus anthracis. Also provided are methods of treating or preventing a Bacillus anthracis infection. The invention also provides methods of passive vaccination of a subject against Bacillus anthracis.
    Type: Application
    Filed: September 8, 2009
    Publication date: March 10, 2011
    Applicant: IQ Therapeutics BV
    Inventors: Herman Groen, Christine Cool-Kebbedies, Kunja S. Slopsema, Hans Westra
  • Methods of producing stable B-lymphocytes
    Patent number: 7807415
    Abstract: The invention provides a method of producing a stable lymphocyte culture and methods of producing monoclonal antibodies.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: October 5, 2010
    Assignee: IQ Therapeutics BV
    Inventors: Herman Groen, Hans H. Westra
  • Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
    Patent number: 7658925
    Abstract: The invention fully humanized monoclonal antibodies that neutralize Bacillus anthracis. Also provided are methods of treating or preventing a Bacillus anthracis infection. The invention also provides methods of passive vaccination of a subject against Bacillus anthracis.
    Type: Grant
    Filed: March 3, 2005
    Date of Patent: February 9, 2010
    Assignee: IQ Therapeutics BV
    Inventors: Herman Groen, Christine Cool-Kebbedies, Kunja S. Slopsema, Hans Westra